March 26 (Reuters) - Ucb SA UCB.BR:
UCB RECEIVES POSITIVE CHMP OPINION FOR NEW ZILBRYSQ (ZILUCOPLAN) PRE-FILLED PEN IN EU FOR ADULTS LIVING WITH GENERALIZED MYASTHENIA GRAVIS
FIRST ONCE-DAILY SUBCUTANEOUS C5 INHIBITOR AVAILABLE AS PRE-FILLED PEN IN EUROPE AS ADD-ON TO STANDARD THERAPY FOR TREATMENT OF GMG IN ADULT PATIENTS WHO ARE ANTI-ACETYLCHOLINE RECEPTOR (ACHR) ANTIBODY POSITIVE
Source text: https://tinyurl.com/4ysfc32z
Further company coverage: UCB.BR
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))